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To determine the extent of colocalization of substance P (SP) and prodynorphin peptides within neurons of the medial nucleus 
of the amygdala fAMe), medial bed nucleus of the stria terminalis (BNSTm) and medial preoptic area (MPOA), we incubated 
colchicine-treated Syrian hamster brain tissue in an antiserum mixture containing rat anti-SP antibody combined with 1 of 3 rabbit 
antibodies against prodynorphin peptides: anti-dynorphin A(1-17), anti-dynorphin B(1-13) or anti-C-peptide. This was followed 
by incubation in a secondary antiserum mixture containing fluorescein-labeiled anti-rabbit and rhodamine-labelled anti-rat 
antibodies. Sections were viewed with an epifluorescence microscope using blue light excitation for fluorescein and green light 
excitation for rhodamine. Colocalization of SP and prodynorphin labelling was observed in neurons of the caudal parts of AMe, 
BNSTm and MPOA, areas which are essential for male mating behavior. The colocalization was most extensive in the dorsolaterai 
part of the caudal MPOA, the caudodorsal part of the BNSTm, and in the posterodorsal subdivision of AMe. Although all 3 
dynorphin peptides coexisted with SP in these areas, dynorphin B did so less than C-peptide, and dynorphin A less than dynorphin 
B. 
INTRODUCTION 
The male Syrian hamster (Mesocricetus auratus) is 
dependent  on chemosensory cues for the initiation of  
normal mating behavior. This behaviorally essential 
chemosensory information is relayed from receptors 
in the vomeronasal  organ and olfactory mucosa 51'6s 
to the accessory and main olfactory bulbs 41, respec- 
tively, and thence, via the lateral olfactory and 
accessory olfactory tracts 1°, to the medial nucleus of  
the amygdala fAMe) ,  where vomeronasal  and olfac- 
tory information appears to be integrated 26'27. From 
the AMe,  axons project  to the medial preoptic area 
( M P O A )  and the medial bed nucleus of the stria 
terminalis (BNSTm) through two fiber pathways, 
the stria terminalis 9'22'24'33, and the ventral amygda- 
lofugal pathway 2s. Bilateral lesions of  any of the 
areas along the chemosensory pathway described 
above, or the fiber tracts connecting them, can 
completely and permanently eliminate normal mat- 
ing behavior in the male hamster  26"29'52'69. 
Although this anatomical circuitry has been stud- 
ied in detail, little is known about  the functional 
interaction of  structures in this system. In this study 
our aim was to identify neurotransmitters localized 
in this pathway. 
Several putative peptide neurotransmitters have 
been identified in the M P O A ,  BNSTm and A M e  in 
the rat 5-7' 15.16,23,30-32,55.60.61,65,70. While studying neu- 
rotransmitters in the hamster  chemosensory path- 
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way, we have identified cell bodies containing 
substance P (SP), dynorphin A(1-17), dynorphin 
B(1-13) and C-peptide (the C-terminus sequence of 
leumorphin, dynorphin B(1-29) 14) in these 3 re- 
gions45.63. 
Both SP and dynorphin have been implicated in 
the control of sexual behavior, but little is known of 
their respective roles in specific brain areas. There is 
considerable evidence that endogenous opioids may 
play an inhibitory role in mating behavior of the 
male Syrian hamster  42"43"71 and the rat  17'20"36"38'44. 
Although most evidence implicates fl-endorphin and 
/~-receptor activation as the main inhibitory system, 
there is also evidence for enkephalinergic 53 influ- 
ences. Recently, however, evidence has been accu- 
mulating that prodynorphin products may actually 
play a facilitatory role in reproduction in the rat 2' 
21,39. Leumorphin (dynorphin B(1-29)), a prodynor- 
phin product, has been demonstrated to facilitate 
female rat sexual behavior 21'56'62. In addition, micro- 
injections of picomolar amounts of dynorphin A into 
the MPOA of a male rat facilitated copulatory 
behavior, whereas injections of morphine were 
inhibitory and saline had no effect 2. Dynorphin B 
injections into the ventral tegmental area have also 
been shown to facilitate mounting behavior in the 
male rat 39. These data clearly demonstrate that, 
while opiates have been generally thought of as 
inhibitory in their effect on sexual behavior, the 
dynorphins as a specific class may play a facilitating 
role. 
The evidence that SP is involved in sexual 
behavior in the rat suggests that it acts as a 
facilitatory neurotransmitter or neuromodulator 13"66. 
Injections of SP into the medial preoptic area-  
anterior hypothalamic area of male rats significantly 
reduces mounting and copulation latencies 12. 
Though the role of SP with respect to male mating 
behavior in the hamster is not clear, we have found 
that SP immunoreactivity is not only present in the 
MPOA, BNSTm and AMe of this species, but that 
the amount of immunoreactivity in these structures 
is influenced by the level of circulating gonadal 
steroids 63. 
Results from our laboratory indicated that the 
distribution of SP-containing cells overlapped that of 
dynorphin-containing cells in the MPOA, BNSTm 
and AMe of the male Syrian hamster. Therefore, in 
the present study we sought to determine if SP and 
the dynorphin peptides coexist within the same 
neurons. To date we are unaware of any evidence for 
SP colocalization with any prodynorphin peptide in 
the rat or hamster with the exception of their 
coexistence within striatal projection neurons in the 
rat 1. A comparison of SP and dynorphin distribution 
in the substantia nigra of the rat brain showed 
considerable overlap 37, but actual colocalization 
within cell bodies was not demonstrated. Colocali- 
zation of these peptides has also been reported in the 
pigeon and turtle basal ganglia 54, and in the guinea 
pig spinal cord 67. Preliminary findings of the work 
presented here have been reported previously in 
abstract form 47. 
MATERIALS AND METHODS 
Adult male Syrian hamsters (Charles River), age 
75-90 days, were housed in groups in a 14:10 
light:dark cycle and given food and water ad libitum. 
Ten hamsters were anesthetized with sodium pento- 
barbital (10 mg/100g b. wt.) and placed in a 
stereotaxic instrument. Two microliters of colchicine 
(160/~g//~l) were injected into the left lateral ventri- 
cle at the level of the septum (ML = +1.5 from 
bregma, AP = +1.5 from bregma and DV = -3:3 
from dura, with bregma and lambda in the same 
horizontal plane). Brains of animals that did not 
receive colchicine were also studied. In these ani- 
mals, both SP and prodynorphin cell labelling was 
virtually absent. This material was, therefore, not 
included in the present study, but has been used in 
separate studies to aid in fiber and terminal identi- 
fication in the prodynorphin and SP systems in the 
hamster brain 46"63. 
Following a survival period of 48 h, the hamsters 
were again anesthetized with pentobarbital (15 mg/ 
100 g b. wt.) and perfused transcardially with 150 ml 
of a 0.1 M phosphate-buffered saline solution (PBS) 
with 0.1% sodium nitrite (for vasodilation), followed 
by 250-300 ml of fixative. The fixative was either a 
4% paraformaldehyde solution in  0.1 M sodium 
phosphate buffer, or a 2% paraformaldehyde and 
0.25% p-benzoquinone solution in 50 mM sodium 
phosphate buffer. The brains were then removed 
from the skull and post-fixed for 1 h (4% parafor- 
maldehyde brains), or for 2 h (p-benzoquinone 
brains) in the perfusion fixative, followed by soaking 
in a solution of 20% sucrose in PBS at 4 oc for at 
least 24 h. Forty-micrometer sections were cut on a 
freezing stage on a sliding microtome and stored at 
4 °C in 0.1 M sodium phosphate buffer and 0.01% 
sodium azide for preservation of tissues. 
The C-peptide (No. 109, bleed 6) antibody used in 
this study was generously provided by Dr. Stanley J. 
Watson Jr., Mental Health Research Institute, Uni- 
versity of Michigan. The dynorphin A(1-17) 
(AK84T) and dynorphin B(1-13) (AKll3T) anti- 
bodies were a generous gift of Dr. Lars Terenius, 
Uppsala University, Uppsala, Sweden. The SP an- 
tibody used was a monoclonal purchased from 
Sera-Lab (Accurate Scientific). Each of the prody- 
norphin antibodies were generated in rabbit while 
the SP antibody was generated in rat. 
The indirect immunofluorescence procedure used 
in this study has been described elsewhere 19'58'59. In 
our studies we used fluorescein isothiocyanate 
(FITC) for detection of prodynorphin peptides and 
rhodamine isothiocyanate (RITC) for detection of 
SP in all brains. The tissues were incubated for 30 
min in 0.022 M potassium phosphate buffered saline 
(KPBS) and transferred to a primary antiserum 
diluted to the desired concentration with a solution 
of 0.3% triton-X in KPBS for 48-60 h. All primary 
antibodies were used in dilutions determined exper- 
imentally to be optimal for staining. Each primary 
incubation mixture contained 1:500 SP plus either 
1:250 dynorphin A, 1:250 dynorphin B or 1:500 
C-peptide antibodies. The mixture of anti-SP plus 
anti-C-peptide, anti-SP plus anti-dynorphin A or 
anti-SP plus anti-dynorphin B will be referred to as 
the 'primary antiserum' mixture in the text. After 
incubation in the primary antiserum, the sections 
were washed 3 x 5 min in KPBS and then incubated 
in a solution containing 1:50 goat anti-rabbit conju- 
gated to FITC and 1:25 goat anti-rat conjugated to 
RITC in the 0.3% triton-X KPBS for 1 h. The 
sections were washed 6-10 times with water, 
mounted on gelatin-coated slides and coverslipped 
with a glycerol-phosphate buffer medium containing 
phenylenediamine for optimal preservation of FITC- 
immunofluorescence 5°. Adjacent sections were 
mounted and stained with Cresyl violet for cytoar- 
chitectonic localization of immunoreactive cells. 
Sections were analyzed with a Leitz Orthoplan 
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fluorescence microscope, using an I2 filter (495 nm 
blue light excitation), inducing green-blue emission 
from FITC, and an N2 filter (525 nm green light 
excitation), inducing red emission from RITC. 
Ten colchicine-treated hamster brains were labelled 
for C-peptide and SP immunoreactivity using the 
above technique. To determine if SP immunoreactivity 
is colocalized with that of other prodynorphin peptides, 
antisera containing anti-SP and either anti-dynorphin 
A(1-17) or anti-dynorphin B(1-13) antibodies were 
used in sections from several brains as well. 
In each of the 10 brains from animals which 
received colchicine, all immunoreacted sections (i.e. 
every 120 gm) through the MPOA, BNSTm and 
AMe were studied, to develop a clear picture of the 
labelling pattern throughout the rostrocaudal extent 
of each nucleus. As the pattern of colocalization 
became clear, specific, non-overlapping, widely 
spaced regions were selected from each of 3 brains 
for closer study. Using 200x magnification, the 
number of single- and double-labelled cells in vari- 
ous microscopic fields within these regions were 
counted using a hand-held counter. Each field in 
which counts were made contained 100-200 immu- 
nolabeUed cells. A cell was considered to be double- 
labelled when it was observed to contain both 
blue-green cytoplasmic labelling under the 12 filter 
and red cytoplasmic labelling under the N2 filter. 
The number of double-labelled cells within a field 
was divided by the total number of SP-containing or 
the total number of dynorphin-containing cells 
counted in that field to generate the values given in 
the results. These numerical data were generated in 
an attempt to convey the extent of colocalization in 
each area, rather than to establish statistical differ- 
ences between the areas described. 
To test the specificity of the antibodies used, a 
series of control procedures were carried out. First, 
the C-peptide/SP antiserum mixture was preab- 
sorbed (i.e. incubated for 1 h at room temperature) 
with a 25/zM concentration of SP peptide (Peninsula 
Labs), a 5-10/~M concentration of rat C-terminus 
peptide (generously donated by Dr. Stanley J. 
Watson Jr.), a 50-100/~M concentration of porcine 
C-terminus peptide (Peninsula Labs) or a 50-100/~M 
concentration of human leumorphin peptide (Pen- 
insula Labs) prior to tissue incubation, to check for 
primary antiserum specificity (self-blocking control). 
Second, the primary C-peptide/SP antiserum was 
incubated with 50-100/~M dynorphin B(1-13) pep- 
tide, dynorphin A(1-17) peptide, dynorphin A(1-  
13) peptide or Leu-enkephalin peptide (Peninsula 
Labs) prior to tissue incubation, to check for 
cross-reactivity of the C-peptide or SP antibodies 
with related opioid peptides (cross-blocking con- 
trol). Third, sections were incubated with only 
anti-SP or anti-C-peptide in the primary antiserum, 
followed by 1 h with both secondary antibodies, to 
check for non-specific background staining which 
might be elicited if the goat anti-rabbit-FITC or goat 
anti-rat-RITC recognized epitopes in the hamster 
brain. Fourth, sections were incubated with only 
anti-SP followed by only goat anti-rabbit-FITC or 
anti-C-peptide followed by only goat anti-rat-RITC 
to insure that the double labelling was not due to 
secondary antibodies recognizing both primaries in 
the tissue. Last, the dynorphin A/SP and dynorphin 
B/SP antisera were preabsorbed prior to immuno- 
histochemistry with 10-25/~M concentrations of the 
same dynorphin A(1-17) and dynorphin B(1-13) 
peptides towards which they were made. The dyn- 
orphin A and SP antibodies have been characterized 
in detail previously 35'58'59. All primary antisera, with 
or without blocking peptides added, were left at 
room temperature for 1 h prior to the beginning of 
incubation. Thus, antisera with no peptides added 
for blocking controls were treated identically to 
those in which the peptides were allowed an hour for 
preabsorption. 
Fig. 1. Schematic representations of coronal sections at 3 
rostrocaudal levels which showed the heaviest double-labelling 
(colocalization) of SP and C-peptide when using a primary 
antiserum containing antibodies to SP and the C-terminus of 
leumorphin. The boxed areas are illustrated with photographs 
in Figs. 2-4. ×, SP-labelled cells; O, C-peptide-labelled cells; 
O, cells staining for both SP and the C-terminus of leumor- 
phin. Abbreviations: ACe, central nucleus of the amygdala; 
AMe, medial nucleus of the amygdala; BL, anterior baso- 
lateral nucleus of the amygdala; BM, basomedial nucleus of 
the amygdala; BNST, bed nucleus of the stria terminalis (e, 
external part; 1, lateral part; m, medial part); f, fomix; LPOA, 
lateral preoptic area; MPOA, medial preoptic area; MPN, 
medial preoptic nucleus; MPNmag, medial preoptic nucleus, 
magnoeellular part; ot, optic tract; PMCo, posteromedial 
cortical nucleus of the amygdala; PT, parataenial nucleus of 
the thalamus; sm, stria medullaris; st, stria terminalis; v, 
lateral ventricle; VMH, ventromedial nucleus of the hypothal- 
amus. 
RESULTS 
In all cases where rat C-peptide (5-10 gM) was 
added to the primary antiserum 1 h prior to tissue 
incubation, SP staining was unaffected but C-peptide 
staining was completely abolished. On the other 
hand, when 25 /~M SP peptide was added all SP 
staining was abolished but C-peptide staining was 
unaffected (see Fig. 4). When 50-100 ~M human 
leumorphin, 50-100/~M porcine C-peptide, 50-100 
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/~M dynorphin A(1-17), 50-100 pM dynorphin 
B(1-13) or 50-100 /~M Leu-enkephalin peptides 
were added to the primary antiserum, neither SP nor 
C-peptide staining was affected. The dynorphin A 
peptide (10=-25/~M) completely abolished dynorphin 
A antibody staining, while having no effect on SP 
staining. The same specificity was found for dyn- 
orphin B as well. When anti-SP was omitted from 
the primary antiserum strong opioid FITC-immuno- 
fluorescence was observed, but no RITC-immuno- 
fluorescence could be detected. When C-peptide, 
dynorphin A or dynorphin B peptide was omitted 
from the primary antiserum, strong SP RITC- 
immunofluorescence could be observed but no opi- 
oid FITC-immunofluorescence was detected. When 
the RITC-anti-rat secondary was used with the 
C-peptide primary, or when the FITC-anti-rabbit 
was used with the SP primary, no fluorescent 
staining was observed, demonstrating that the sec- 
ondary antisera did not recognize epitopes in ham- 
ster brain tissue. 
Both the benzoquinone-paraformaldehyde perfu- 
sion mixture, and the paraformaldehyde perfusion 
mixture gave excellent SP and prodynorphin fluo- 
rescent staining in the brain areas described in this 
paper. 
Both FITC- and RITC-labelled cells had a dif- 
fusely labelled and brightly fluorescent cytoplasm. In 
Fig. 2. Photomicrographs of SP and C-peptide immunostaining observed in the same section of the dorsolateral MPOA (Fig. 1, box 
1). A: FITC-fluorescence of C-peptide immunoreactivity. B: RITC-fluorescence of SP immunoreactivity. Arrows identify 
representative neurons immunoreactive for both SP and the C-terminus of leumorphin, while arrowheads identify neurons labelled 
for only one peptide. Calibration bar = 100 gm. 
Fig. 31 Photomicrographs of SP and C-peptide immunostaining observed in the same section of the BNSTm (Fig. 1, box 2). A: 
FITC-fluorescence of C-peptide immunoreactivity. B: RITC-fluorescence of SP immunoreactivity. Arrows identify representative 
neurons immunoreactive for both SP and the C-terminus of leumorphin, while the arrowhead identifies a neuron labelled for only 
C-peptide. At  this level, fiber and terminal labelling for both C-peptide and SP is intense, obscuring many cell bodies located within 
this part of the nucleus. LV, lateral ventricle. Calibration bar = 100 #m. 
many cases the dendritic processes of the cells could 
also be visualized. In areas where fiber labelling was 
light (e.g. the MPOA) cells were readily distinguish- 
able from the background by their shape. In other 
areas (e.g. the BNSTm) the density and intensity of 
fiber and terminal labelling was great enough to 
obscure the outlines of some labelled cells. Thus, the 
percentage of colocalization presented ,la~re may be 
a conservative estimate of the actual number of cells 
containing each peptide. 
Numerous SP and prodynorphin cells have been 
demonstrated in the MPOA, BNSTm and AMe in 
the hamster brain using peroxidase-antiperoxidase 
immunohistochemistry and light microscopy 45"63. 
Fig. 4. Photomicrographs showing FITC-fluorescence of C-peptide immunoreactivity, (A), and RITC-fluorescence of SP 
immunoreactivity, (B), in the same section of the AMe (Fig. 1, box 3). C: FITC-fluorescence in an adjacent section to (A) above 
with 10/tM of rat C-terminus peptide added to the primary antiserum 1 h prior to tissue incubation. D: RITC-fluorescence in an 
adjacent section to (B) above with 25/~M of SP peptide added to the primary antiserum 1 h prior to tissue incubation. These 
micrographs demonstrate the complete absence of immunolabelling consistently observed with preabsorption control studies in all 
areas observed. See text for details. Arrows identify examples of neurons immunoreactive for both SP and the C-terminus of 
leumorphin, while the arrowhead identifies a neuron labelled for only C-peptide. At this level, fiber and terminal labelling for both 




The results of the present study confirmed these 
preliminary findings using immunofluorescence his- 
tochemistry. In all 3 areas the C-peptide antibody 
labelled the largest number of cell bodies while the 
dynorphin B antibody labelled fewer cell bodies and 
the dynorphin A antibody labelled the least. Since 
the C-peptide antibody produced the most robust 
labelling and showed a similar distribution to SP, we 
investigated the colocalization of these two peptides 
in detail. The SP/dynorphin B and SP/dynorphin A 
colocalization we observed in these same areas is 
also described below. 
Though the degree of SP and prodynorphin 
colocalization was consistent from animal to animal, 
there were differences in the number of double- 
labelled cells between the BNSTm, MPOA and 
AMe as well as differences in the number and 
distribution of double-labelled cells within subdivi- 
sions of these nuclei. Lastly, there was variation in 
the degree of colocalization among the 3 different 
dynorphin antibodies. 
Medial preoptic area 
The most rostral level of the MPOA at which 
double-labelled cells were found was the mid-level of 
the body of the anterior commissure. At this level 
SP- and C-peptide-immunolabelled cells were few in 
number and confined to its lateral extent, where 
one-third of SP cells were observed to contain 
C-peptide and one-quarter of the C-peptide cells 
contained SP. 
At the caudal edge of the body of the anterior 
commissure, the proportion of double-labelled cells 
increased throughout the MPOA (one-half of SP- 
labelled cells contained C-peptide; the same propor- 
tion of C-peptide cells contained SP), though the 
number of single-labelled SP and C-peptide cells had 
only increased slightly. Within the medial preoptic 
nucleus (MPN) at this level, numerous cells showed 
C-peptide staining, but SP-labelled cells were scarce. 
As few as 1 in 100 of these numerous C-peptide cells 
contained SP whereas 1 in 4 of the scattered SP cells 
were also stained for C-peptide. This staining pat- 
tern continued throughout the MPN. 
Caudal to the body of the anterior commissure the 
number of SP- and C-peptide-immunolabelled cells 
remained the same but the percentage of double- 
labelled cells increased significantly, particularly in 
the dorsolateral part of the MPOA. In this area 
three-quarters of the SP cells were also labelled 
with the C-peptide antibody and two-thirds of the 
C-peptide cells contained SP (Fig. 1, box 1 and 
Fig. 2). In the ventrolateral MPOA, lateral to the 
MPN, slightly more than one-third of the SP cells 
labelled for C-peptide, while one-fourth to one-third 
of the C-peptide cells were double-labelled for 
SP. 
When the primary antiserum contained antibodies 
to dynorphin B(1-13) combined with SP antibodies, 
numerous double-labelled cells were observed in the 
MPOA, in a pattern indistinguishable from that of 
C-peptide/SP double-labelling. However, since few- 
er dynorphin B cells were observed, the proportion 
of SP cells containing dynorphin B was less than that 
of SP cells containing C-peptide. For example, in the 
dorsolateral part of the caudal MPOA where about 
one-half of SP cells contained C-peptide, approxi- 
mately two-fifths of SP cells contained dynorphin B, 
and the same proportion of dynorphin B cells 
showed SP-labelling. 
There were only occasional dynorphin A-con- 
taining cells in the MPOA, and some of these also 
contained SP. In the dorsolateral part of this area, 
where C-peptide/SP and dynorphin B/SP double- 
labelling were heaviest, only 1 in 10 SP cells 
contained dynorphin A, while half of the small 
number of dynorphin A cells contained SP. 
Bed nucleus of  the stria terminalis, medial division 
SP-labelled cells were found rostrally in the 
BNSTm, rostral to the body of the anterior com- 
missure, whereas few C-peptide-tabelled cells were 
observed in this area. As a result, double-labelled 
cells were not observed in this region. From the 
caudal border of the anterior commissure to the 
most caudal part of the BNSTm, cells containing 
both C-peptide and SP were observed along its 
dorsal border (Fig. 1, box 2 and Fig. 3). In this 
region one-third to one-half of all SP cells contained 
C-peptide. C-peptide cells containing SP also ranged 
from one-third to one-half at more rostral levels but 
decreased to one-fifth more caudally, where C- 
peptide cell numbers increased. At this caudal level 
in the BNSTm, fiber and terminal labelling for both 
C-peptide and SP was quite heavy (Fig. 3). The SP 
fiber/terminal labelling was heavier than that of 
C-peptide in most brain areas. However, in the 
caudal dorsal part of the BNSTm the C-peptide fiber 
and terminal labelling was more intense. 
In the ventral part of the BNSTm, the number of 
double-labelled cells was low, although numerous SP 
and C-peptide cells were present. Throughout the 
rostrocaudal extent of this ventral region approxi- 
mately one-fourth of the cells containing SP coloca- 
lized with C-peptide while even fewer C-peptide- 
containing cells labelled for SP. This pattern of 
strong double-labelling dorsally and less double- 
labelling ventrally continued throughout the bed 
nucleus with one exception; in the preoptic part of 
the bed nucleus of the stria terminalis approximately 
half of both SP and C-peptide cells were observed to 
be double-labelled. 
The dynorphin B staining pattern in the BNSTm 
was quite similar to that of C-peptide, both in quality 
and quantity. As a result, dynorphin B and SP 
double-labelling patterns were essentially identical 
to that described for C-peptide and SP above. There 
were fewer dynorphin A immunoreactive cell bodies 
in the BNSTm than observed with C-peptide anti- 
body. As a result, in the dorsal part of this nucleus, 
where SP and C-peptide (or dynorphin B) double- 
labelled cells were the most numerous, only 1 in 10 
cells containing SP were observed to colocalize with 
dynorphin A, while half of the dynorphin A-labelled 
cells also contained SP. 
Medial nucleus of the amygdala 
C-peptide-labelling was observed in the most 
rostral extent of the anterior dorsal subdivision of 
the AMe, but SP-labelled cells were confined to the 
caudal one-third. Throughout this caudal region, 
individually labelled SP and C-peptide cells filled the 
posterodorsal subdivision (Fig. 1, box 3 and Fig. 4). 
At midcaudal levels of the AMe a moderate 
number of both SP and C-peptide-labelled neurons 
were observed. However, no double-labelled cells 
were found. From this level to the most caudal tip of 
the nucleus, double-labelled SP and C-peptide cells 
were numerous in the posterodorsal subdivision. 
SP-labeUed cells containing C-peptide ranged from 
one-half in the rostral part of the posterodorsal 
AMe, to four-fifths in its caudal tip. C-peptide- 
labelled cells containing SP showed a similar pro- 
portion of double-labelling. C-peptide and SP colo- 
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calization was mostly confined to the dorsal part of 
the posterodorsal subdivision, with the ventral part 
of this subdivision demonstrating only 1 in 5 SP or 
C-peptide cells that were double-labelled. 
When dynorphin B antibody was used in the 
primary antiserum we observed numerous dynorphin 
B-labelled cells in the caudal regions of the AMe. 
However, in the caudal tip there were fewer SP cells 
containing dynorphin B (two-fifths) and fewer dyn- 
orphin B cells containing SP (one-third) than were 
observed with C-peptide and SP, even though there 
was no appreciable drop in the number of labelled 
cells in this area. With dynorphin A antibody, we 
again observed the same pattern of fewer immuno- 
labelled cells, with a lower SP ratio and higher 
dynorphin A ratio of double-labelling. For example, 
in the caudal tip of the AMe, where as much as 
four-fifths of the C-peptide and SP cells were 
double-labelled, only one-third of SP cells contained 
dynorphin A while two-thirds of the scattered 
dynorphin A cells contained SP. Again, these large 
variations in ratios were due to a significantly smaller 
number of labelled neurons when using dynorphin 
A, rather than C-peptide antibody, in the primary 
antiserum mixture. 
DISCUSSION 
Using indirect immunofluorescence histochemis- 
try we have demonstrated the colocalization of 
SP-like and prodynorphin-like immunoreactivity in 
the MPOA, BNSTm and the posterodorsal subdivi- 
sion of the AMe. Colocalization of SP and prody- 
norphin was confined to cells in the caudal parts of 
all these brain areas and, within these caudal 
regions, the double-labelled cells were more numer- 
ous in the dorsolateral than in the ventromedial 
territory of each nucleus. 
At first glance the dorsolateral-ventromedial gra- 
dient of colocalization may appear to be related to 
colchicine effects due to the close proximity of the 
BNSTm and AMe to the lateral ventricle. However, 
this is not the case in the MPOA, where heaviest 
double-labelling was observed dorsolaterally, further 
from the third ventricle than the location of many 
single-labelled cells. The preoptic part of the bed 
nucleus of the stria terminalis, the part of the 
BNSTm located furthest from the ventricle, also 
showed strong double-labelling. It should be stressed 
that the patterns of SP and dynorphin labelling in the 
present study reflect those obtained from tissue 
processed with individual antisera. The pattern of 
double-labelling is greatest in those areas in which 
the individual SP and dynorphin immunostaining 
patterns overlap. This suggests that the gradients of 
colocalization are related to the expression of these 
peptides rather than the location of colchicine 
placement. Other studies report similar distributions 
of dynorphin and SP cells with a pattern clearly not 
dependent on colchicine treatment 7'15. 
In general, dynorphin B and dynorphin A were 
found within neurons containing SP with the same 
distribution as C-peptide, but were fewer in number. 
Dynorphin B cells were slightly fewer in number 
than those labelled with the C-peptide antibody, 
while dynorphin A antibody labelled the smallest 
number of cells. Therefore, in comparison to cells 
showing both SP and C-peptide immunoreactivity, 
fewer cells containing both SP and either dynorphin 
A or dynorphin B peptides were observed. 
Since all 3 of these prodynorphin sequences 
(dynorphin A(1-17), dynorphin B(1-13) and C- 
peptide) are found for the same precursor molecule, 
there are several possible explanations for variations 
in antibody labelling observed within these 3 pep- 
tides. The first possibility is that the antisera have 
differential affinities for their respective peptides. 
The C-peptide antiserum may recognize the C- 
peptide sequence more effectively than the dyn- 
orphin B antiserum recognizes its sequence. The 
dynorphin B antiserum may, in turn, recognize its 
sequence more efficiently than does the dynorphin A 
antibody. Another possibility is that our perfusion 
techniques preserved peptide sequences differenti- 
ally (C-peptide > dynorphin B > dynorphin A) and 
that the differences in the affinity of the antisera for 
their peptides are due to the effect of the perfusion 
rather than the nature of the antisera used. A third 
possibility is that a combination of the two factors is 
involved. These suggestions are supported by the 
observation that higher concentrations of dynorphin 
A and dynorphin B antisera than the C-peptide 
antiserum are required for adequate immunolabel- 
ling. However, we have observed in separate studies 
that, under identical conditions to those used in this 
study on the hamster material, all 3 prodynorphin 
peptides produced identical staining patterns 
throughout the rat brain 46. In addition, in several 
areas of the hamster brain other than the 3 reported 
here, the dynorphin A and dynorphin B antisera 
produce heavier immunolabelling patterns in both 
cells and fibers than the C-peptide antiserum (e.g. 
lateral hypothalamus, arcuate nucleus) 46. Neither 
differential affinities of antisera to their peptide 
sequences nor differential perfusion effects ade- 
quately explain these observations. 
One other possible explanation is differential 
processing of the prodynorphin precursor peptide in 
various regions of the hamster brain. Differential 
processing of the prodynorphin precursor molecule 
has been demonstrated in homogenates of the rat 
brain and pituitary with radioimmunoassay, gel 
filtration and high pressure liquid chromatography 57. 
In the hamster brain the precursor molecule may be 
cleaved to produce dynorphin A(1-8 or 1-17), 
dynorphin B(1-13) or leumorphin (dynorphin B(1- 
29)) in varying amounts in different nuclei to such an 
extent that immunocytochemical detection of these 
peptide products in nerve cell bodies differs with 
each prodynorphin antiserum used. 
The presence of SP and prodynorphin in the 
MPOA, BNSTm and AMe suggests that both SP and 
products of the prodynorphin precursor may partic- 
ipate in the chemosensory control of male sexual 
behavior. SP has been reported to facilitate mating 
behavior when injected into the MPOA of the male 
rat by shortening mounting and ejaculation laten- 
cies 12. Though parallel behavioral effects of leumor- 
phin have not been studied in the male, dynorphin 
A injected into the MPOA has also been shown to 
induce copulatory behavior 2, and injections of dyn- 
orphin B into the ventral tegmental area facilitates 
male mounting 39. 
Additional anatomical and physiological evidence 
further supports the notion that SP and opioid 
peptides play a role in mediating sexual behavior. 
Opiate 18 and SP 48 receptors have been localized in 
the MPOA, BNSTm and AMe in the rat and in the 
MPOA of the hamster 49, and SP has been shown to 
increase firing in neurons of both the M P O A  34 and 
the AMe 4 in the rat. 
The colocalization of SP and prodynorphin opioid 
peptides suggests that they may interact to regulate 
neuronal function. SP has been shown to regulate 
the secretion of proenkephalin peptides. Adminis- 
tration of  SP induces the release of  MetS-enkephalin 
from striatal and periaqueductal gray brain slices 8 
and stimulates the release of MetLenkephalin and 
MetS-enkephalin-Arg6-Phe 7 from rat spinal cord 64. If 
SP has the same effect on prodynorphin products, 
then SP could induce release of  leumorphin, dyn- 
orphin A or  dynorphin B from nerve terminals which 
contain both SP and a prodynorphin peptide. This 
mechanism has been proposed for SP-induced re- 
lease of  thyrotropin releasing hormone in the ventral 
spinal cord of the rat 3. 
As circulating gonadal steroids play a major  role 
in the regulation of  mating behavior, an important 
question is whether SP or prodynorphin production 
is regulated by these hormones.  Neurons in the 
AMe,  M P O A  and BNSTm of the hamster actively 
accumulate androgens 1~ and estrogens eS. The colo- 
calization of  SP and prodynorphin peptides within 
neurons in these areas raises the possibility that 
these peptides mediate steroidal regulation of  mat- 
ing behavior. We have recently reported that the 
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